Valuation: EUROAPI

Capitalization 138M 161M 126M 121M 221M 15.41B 225M 1.52B 587M 7.32B 603M 590M 25.49B P/E ratio 2026 *
-1.82x
P/E ratio 2027 * -3.94x
Enterprise value 96.55M 112M 88.28M 84.23M 154M 10.77B 157M 1.06B 410M 5.11B 421M 412M 17.8B EV / Sales 2026 *
0.13x
EV / Sales 2027 * 0.17x
Free-Float
64.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week-4.41%
Current month+4.38%
1 month+10.51%
3 months-36.16%
6 months-54.75%
Current year-37.00%
1 week 1.42
Extreme 1.42
1.57
1 month 1.26
Extreme 1.26
1.57
Current year 1.22
Extreme 1.22
2.28
1 year 1.22
Extreme 1.22
3.57
3 years 1.22
Extreme 1.22
12.97
5 years 1.22
Extreme 1.22
19.02
10 years 1.22
Extreme 1.22
19.02
Manager TitleAgeSince
Chief Executive Officer - 08/12/2024
Director of Finance/CFO - 16/10/2024
Compliance Officer - 26/11/2023
Director TitleAgeSince
Director/Board Member 62 05/05/2022
Director/Board Member - 05/05/2022
Chairman 57 08/12/2024
Change 5d. change 1-year change 3-years change Capi.($)
-1.52%-4.41%-46.92%-86.04% 161M
-0.18%+5.95%+32.68%+129.71% 896B
-1.77%+2.44%+49.81%+42.59% 546B
-0.18%+4.39%+14.33%+46.77% 372B
-0.81%+2.38%+24.30%+13.90% 328B
+0.05%+2.78%+27.65%+29.11% 283B
-0.24%+0.90%+31.35%+13.74% 282B
-1.79%0.00%+46.44%-2.95% 275B
-3.26%-3.55%-34.04%-50.95% 206B
-2.95%-1.62%+19.79%+45.01% 176B
Average -1.09%+1.89%+16.54%+18.09% 336.35B
Weighted average by Cap. -0.89%+3.17%+28.44%+50.58%

Financials

2026 *2027 *
Net sales 760M 884M 695M 663M 1.22B 84.79B 1.24B 8.34B 3.23B 40.25B 3.32B 3.25B 140B 804M 935M 736M 702M 1.29B 89.69B 1.31B 8.82B 3.41B 42.58B 3.51B 3.43B 148B
Net income -75.7M -87.97M -69.22M -66.04M -121M -8.44B -123M -830M -321M -4.01B -330M -323M -13.96B -40.25M -46.78M -36.8M -35.11M -64.37M -4.49B -65.44M -442M -171M -2.13B -176M -172M -7.42B
Net Debt -41.66M -48.42M -38.09M -36.34M -66.63M -4.65B -67.73M -457M -177M -2.21B -182M -178M -7.68B -5.06M -5.88M -4.63M -4.42M -8.1M -565M -8.23M -55.54M -21.49M -268M -22.08M -21.61M -934M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
18/05/26 1.430 -1.52% 55,194
15/05/26 1.452 -2.55% 249,014
14/05/26 1.490 +1.36% 342,969
13/05/26 1.470 +1.38% 49,904
12/05/26 1.450 -3.07% 280,579
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
1.452EUR
Average target price
1.760EUR
Spread / Average Target
+21.21%

Quarterly revenue - Rate of surprise